We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-12.49%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$48.6B
AUM Growth
-$4.2B
(-8%)
Cap. Flow
+$3.6B
Cap. Flow
% of AUM
7.4%
Top 10 Holdings %
Top 10 Hldgs %
10.29%
Holding
4,108
New
835
Increased
963
Reduced
740
Closed
743
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$340M |
| 2 |
Bank of America
BAC
|
+$302M |
| 3 |
Cigna
CI
|
+$294M |
| 4 |
TSMC
TSM
|
+$275M |
| 5 |
Union Pacific
UNP
|
+$256M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$426M |
| 2 |
S&P Global
SPGI
|
+$413M |
| 3 |
Booking.com
BKNG
|
+$264M |
| 4 |
Comcast
CMCSA
|
+$256M |
| 5 |
Teleflex
TFX
|
+$241M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Financials | 16.96% |
| 3 | Technology | 16.37% |
| 4 | Consumer Discretionary | 9.32% |
| 5 | Industrials | 7.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CCVI
401
DELISTED
Churchill Capital Corp VI
CCVI
| $23.3M | 0.05% |
2,376,633
+1,268,254
| +114% | +$12.4M |
|
|
ARCH
402
DELISTED
Arch Resources, Inc.
ARCH
| $23.2M | 0.05% |
162,473
-86,332
| -35% | -$13.7M |
|
|
PR
403
Permian Resources
PR
$16.9B
| $23.2M | 0.05% |
3,884,033
-6,535,235
| -63% | -$52.2M |
|
|
BOAC
404
DELISTED
Bluescape Opportunities Acquisition Corp.
BOAC
| $23.1M | 0.05% |
2,326,812
| – | – |
|
405
Teck Resources
TECK
$32.6B
| $23M | 0.05% |
751,922
-2,129,597
| -74% | -$84M |
|
406
PUT
KraneShares CSI China Internet ETF
KWEB
$5.67B
| $22.8M | 0.05% |
695,500
+357,800
| +106% | +$10.3M |
|
|
GSEV
407
DELISTED
Gores Holdings VII, Inc. Class A Common Stock
GSEV
| $22.8M | 0.05% |
2,329,291
+21,546
| +0.9% | +$211K |
|
408
Duke Energy
DUK
$97.3B
| $22.7M | 0.05% |
211,925
-39,717
| -16% | -$4.37M |
|
|
HHLA
409
DELISTED
HH&L Acquisition Co.
HHLA
| $22.7M | 0.05% |
2,311,227
| – | – |
|
410
Ball Corp
BALL
$16.8B
| $22.6M | 0.05% |
328,300
+115,773
| +54% | +$8.79M |
|
411
Hewlett Packard
HPE
$70.5B
| $22.6M | 0.05% |
1,700,741
-493,296
| -22% | -$7.48M |
|
412
Monster Beverage
MNST
$88.5B
| $22.5M | 0.05% |
485,204
-1,419,742
| -75% | -$61.7M |
|
413
Cloudflare
NET
$107B
| $22.5M | 0.05% |
513,202
+404,818
| +374% | +$29.2M |
|
414
WIX.com
WIX
$2.52B
| $22.3M | 0.05% |
+340,374
| New | +$24.9M |
|
|
TPTX
415
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $22.3M | 0.05% |
+296,462
| New | +$13.2M |
|
416
PUT
State Street Energy Select Sector SPDR ETF
XLE
$37.7B
| $22.3M | 0.05% |
623,600
-1,651,800
| -73% | -$66.3M |
|
|
COHR
417
DELISTED
Coherent Inc
COHR
| $22.3M | 0.05% |
83,649
+21,163
| +34% | +$5.67M |
|
418
Weibo
WB
$1.95B
| $22.1M | 0.05% |
954,398
+245,212
| +35% | +$5.49M |
|
|
NEWR
419
DELISTED
New Relic, Inc.
NEWR
| $22.1M | 0.05% |
441,035
-686,800
| -61% | -$38.1M |
|
|
KVSC
420
DELISTED
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
| $21.9M | 0.05% |
2,248,297
+744,038
| +49% | +$7.26M |
|
421
B&G Foods
BGS
$286M
| $21.9M | 0.05% |
+919,357
| New | +$22.9M |
|
422
Allegion
ALLE
$14.4B
| $21.8M | 0.04% |
+222,816
| New | +$24.2M |
|
423
PUT
Berkshire Hathaway Class B
BRK.B
$1.13T
| $21.7M | 0.04% |
79,600
-5,700
| -7% | -$1.79M |
|
424
Blackrock
BLK
$176B
| $21.7M | 0.04% |
35,651
-69,198
| -66% | -$45.1M |
|
|
TSPQ
425
DELISTED
TCW Special Purpose Acquisition Corp.
TSPQ
| $21.7M | 0.04% |
2,226,371
| – | – |
|
Similar funds
Marshall Wace's Q2 2022 Portfolio in Review
As of Q2 2022, Marshall Wace held 4,108 positions worth $48.6B, down 8% from $52.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Marshall Wace deployed $3.6B of net new capital in Q2 2022, opening 835 new positions and adding to 963 existing holdings. Its largest new stake was Eli Lilly: 1,133,393 shares worth $367M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Verizon, an estimated $426M trimmed.
- Marshall Wace's largest Q2 2022 buy was Eli Lilly: 1,133,393 shares worth $367M.
- Marshall Wace added most to Bank of America in Q2 2022, an estimated $302M increase.
- Marshall Wace's biggest Q2 2022 reduction was Verizon, cutting an estimated $426M.
- Marshall Wace fully exited Teleflex in Q2 2022, selling an estimated $241M.
- Marshall Wace's ten largest holdings make up 10% of its $48.6B portfolio in Q2 2022.
- Marshall Wace opened 835 new positions and closed 743 in Q2 2022.
- Marshall Wace's portfolio value fell 8% quarter-over-quarter to $48.6B.
Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.